Glebova KV - Search Results

1

Oxidized extracellular DNA suppresses nitric oxide production by endothelial NO synthase (eNOS) in human endothelial cells (HUVEC).

Kostyuk SV, Alekseeva AY, Kon'kova MS, Glebova KV, Smirnova TD, Kameneva LV, Izhevskaya VL, Veiko NN. Kostyuk SV, et al. Among authors: glebova kv. Bull Exp Biol Med. 2014 Jun;157(2):202-6. doi: 10.1007/s10517-014-2525-x. Epub 2014 Jun 22. Bull Exp Biol Med. 2014. PMID: 24952486

2

Properties of extracellular DNA from the cerebrospinal fluid and blood plasma during Parkinson's disease.

Glebova KV, Konorova IL, Poleshchuk VV, Baidakova GV, Veiko NN. Glebova KV, et al. Bull Exp Biol Med. 2014 Apr;156(6):826-8. doi: 10.1007/s10517-014-2461-9. Epub 2014 May 3. Bull Exp Biol Med. 2014. PMID: 24824708

3

Extracellular DNA oxidation stimulates activation of NRF2 and reduces the production of ROS in human mesenchymal stem cells.

Loseva P, Kostyuk S, Malinovskaya E, Clement N, Dechesne CA, Dani C, Smirnova T, Glebova K, Baidakova G, Baranova A, Izhevskaia V, Ginter E, Veiko N. Loseva P, et al. Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S85-97. doi: 10.1517/14712598.2012.688948. Epub 2012 May 18. Expert Opin Biol Ther. 2012. PMID: 22594577

4

Role of extracellular DNA oxidative modification in radiation induced bystander effects in human endotheliocytes.

Kostyuk SV, Ermakov AV, Alekseeva AY, Smirnova TD, Glebova KV, Efremova LV, Baranova A, Veiko NN. Kostyuk SV, et al. Among authors: glebova kv. Mutat Res. 2012 Jan 3;729(1-2):52-60. doi: 10.1016/j.mrfmmm.2011.09.005. Epub 2011 Oct 4. Mutat Res. 2012. PMID: 22001237

5

Oxidized DNA induces an adaptive response in human fibroblasts.

Kostyuk SV, Tabakov VJ, Chestkov VV, Konkova MS, Glebova KV, Baydakova GV, Ershova ES, Izhevskaya VL, Baranova A, Veiko NN. Kostyuk SV, et al. Among authors: glebova kv. Mutat Res. 2013 Jul-Aug;747-748:6-18. doi: 10.1016/j.mrfmmm.2013.04.007. Epub 2013 May 1. Mutat Res. 2013. PMID: 23644378

6

Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy.

Glebova K, Veiko N, Kostyuk S, Izhevskaya V, Baranova A. Glebova K, et al. Cancer Lett. 2015 Jan 1;356(1):22-33. doi: 10.1016/j.canlet.2013.09.005. Epub 2013 Sep 14. Cancer Lett. 2015. PMID: 24045040 Review.

7

Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives.

Glebova KV, Veiko NN, Nikonov AA, Porokhovnik LN, Kostuyk SV. Glebova KV, et al. Crit Rev Clin Lab Sci. 2018 Jan;55(1):55-70. doi: 10.1080/10408363.2017.1420032. Epub 2018 Jan 5. Crit Rev Clin Lab Sci. 2018. PMID: 29303618 Review.

8

siRNA technology in kidney transplantation: current status and future potential.

Glebova K, Reznik ON, Reznik AO, Mehta R, Galkin A, Baranova A, Skoblov M. Glebova K, et al. BioDrugs. 2014 Aug;28(4):345-61. doi: 10.1007/s40259-014-0087-0. BioDrugs. 2014. PMID: 24573958 Review.

9

[Therapeutic siRNAs and non-viral systems for their delivery].

Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu. Glebova KV, et al. Mol Biol (Mosk). 2012 May-Jun;46(3):371-86. Mol Biol (Mosk). 2012. PMID: 22888628 Review. Russian.

10

[Types of non-viral delivery systems of small interfering RNA].

Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu. Glebova KV, et al. Mol Biol (Mosk). 2012 May-Jun;46(3):387-401. Mol Biol (Mosk). 2012. PMID: 22888629 Review. Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters